Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing Exubera® (Insulin Dry Powder Pulmonary Inhaler) vs. Avandia® (Rosiglitazone Maleate) as Add-On Therapy vs. Exubera® Substitution of Sulfonylurea in Patients With Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and Metformin Treatment
1 other identifier
interventional
626
5 countries
119
Brief Summary
- Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination therapy of metformin and a sulfonylurea plus Avandia, a Food and Drug Administration (FDA) approved drug.
- Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 diabetes-mellitus
Started Jan 2003
Longer than P75 for phase_3 diabetes-mellitus
119 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 6, 2005
CompletedFirst Posted
Study publicly available on registry
September 8, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedOctober 31, 2008
October 1, 2008
September 6, 2005
October 28, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Glycosylated hemoglobin
Secondary Outcomes (4)
Change from baseline in fasting plasma glucose. Other secondary efficacy
endpoints include, body weight, patient reported outcomes, incidence and severity
of hypoglycemic episodes, cough questionnaire, and discontinuation rate due to
insufficient clinical response.
Interventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetes
- Currently treated and on a stable doses of drugs for the preceding two (2) months
You may not qualify if:
- Type 1 Diabetes
- Smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (119)
Pfizer Investigational Site
Mesa, Arizona, 85205, United States
Pfizer Investigational Site
Phoenix, Arizona, 85012, United States
Pfizer Investigational Site
Tucson, Arizona, 85715, United States
Pfizer Investigational Site
Searcy, Arkansas, 72143, United States
Pfizer Investigational Site
Alhambra, California, 91801, United States
Pfizer Investigational Site
Concord, California, 94520, United States
Pfizer Investigational Site
Huntington Beach, California, 92647, United States
Pfizer Investigational Site
Huntington Beach, California, 92648, United States
Pfizer Investigational Site
La Jolla, California, 92037, United States
Pfizer Investigational Site
Long Beach, California, 90805, United States
Pfizer Investigational Site
Long Beach, California, 90806, United States
Pfizer Investigational Site
Los Angeles, California, 90048, United States
Pfizer Investigational Site
Riverside, California, 92506, United States
Pfizer Investigational Site
Santa Barbara, California, 93105, United States
Pfizer Investigational Site
Tustin, California, 92780, United States
Pfizer Investigational Site
Westminster, California, 92683, United States
Pfizer Investigational Site
Denver, Colorado, 80209, United States
Pfizer Investigational Site
Wheat Ridge, Colorado, 80033, United States
Pfizer Investigational Site
Waterbury, Connecticut, 06708, United States
Pfizer Investigational Site
Washington D.C., District of Columbia, 20010, United States
Pfizer Investigational Site
Washington D.C., District of Columbia, 20307, United States
Pfizer Investigational Site
Hollywood, Florida, 33021, United States
Pfizer Investigational Site
West Palm Beach, Florida, 33401, United States
Pfizer Investigational Site
Winter Park, Florida, 32789, United States
Pfizer Investigational Site
Atlanta, Georgia, 30309, United States
Pfizer Investigational Site
Augusta, Georgia, 30909, United States
Pfizer Investigational Site
Savannah, Georgia, 31405, United States
Pfizer Investigational Site
Savannah, Georgia, 31419, United States
Pfizer Investigational Site
Honolulu, Hawaii, 96813, United States
Pfizer Investigational Site
‘Ewa Beach, Hawaii, 96706, United States
Pfizer Investigational Site
Idaho Falls, Idaho, 83404-6370, United States
Pfizer Investigational Site
Idaho Falls, Idaho, 83404-7542, United States
Pfizer Investigational Site
Chicago Heights, Illinois, 60411, United States
Pfizer Investigational Site
Indianapolis, Indiana, 46202, United States
Pfizer Investigational Site
Des Moines, Iowa, 50314, United States
Pfizer Investigational Site
Wichita, Kansas, 67203, United States
Pfizer Investigational Site
Lexington, Kentucky, 40503, United States
Pfizer Investigational Site
Louisville, Kentucky, 40213, United States
Pfizer Investigational Site
Baton Rouge, Louisiana, 70808, United States
Pfizer Investigational Site
New Orleans, Louisiana, 70112, United States
Pfizer Investigational Site
Baltimore, Maryland, 21204, United States
Pfizer Investigational Site
Springfield, Massachusetts, 01103, United States
Pfizer Investigational Site
Springfield, Massachusetts, 01199, United States
Pfizer Investigational Site
Waltham, Massachusetts, 02453, United States
Pfizer Investigational Site
West Saint Paul, Minnesota, 55118, United States
Pfizer Investigational Site
North Kansas City, Missouri, 64116, United States
Pfizer Investigational Site
St Louis, Missouri, 63141, United States
Pfizer Investigational Site
Butte, Montana, 59701, United States
Pfizer Investigational Site
Lincoln, Nebraska, 68521, United States
Pfizer Investigational Site
New Brunswick, New Jersey, 08901, United States
Pfizer Investigational Site
New Brunswick, New Jersey, 08903, United States
Pfizer Investigational Site
Albuquerque, New Mexico, 87106, United States
Pfizer Investigational Site
Albany, New York, 12208, United States
Pfizer Investigational Site
Flushing, New York, 11365, United States
Pfizer Investigational Site
Mineola, New York, 11501, United States
Pfizer Investigational Site
New Hyde Park, New York, 11042, United States
Pfizer Investigational Site
Rochester, New York, 14642, United States
Pfizer Investigational Site
Raleigh, North Carolina, 27609, United States
Pfizer Investigational Site
Cincinnati, Ohio, 45229, United States
Pfizer Investigational Site
Cleveland, Ohio, 44195, United States
Pfizer Investigational Site
Lakewood, Ohio, 44107, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, 73104, United States
Pfizer Investigational Site
Portland, Oregon, 97210, United States
Pfizer Investigational Site
Pittsburgh, Pennsylvania, 15235, United States
Pfizer Investigational Site
Charleston, South Carolina, 29401-5799, United States
Pfizer Investigational Site
Charleston, South Carolina, 29425, United States
Pfizer Investigational Site
Duncan, South Carolina, 29334, United States
Pfizer Investigational Site
Spartanburg, South Carolina, 29303, United States
Pfizer Investigational Site
Spartanburg, South Carolina, 29307, United States
Pfizer Investigational Site
Sumter, South Carolina, 29150, United States
Pfizer Investigational Site
Kingsport, Tennessee, 37660, United States
Pfizer Investigational Site
Knoxville, Tennessee, 37909, United States
Pfizer Investigational Site
Memphis, Tennessee, 38119, United States
Pfizer Investigational Site
Nashville, Tennessee, 37232, United States
Pfizer Investigational Site
Corpus Christi, Texas, 78411, United States
Pfizer Investigational Site
Dallas, Texas, 75230, United States
Pfizer Investigational Site
Dallas, Texas, 75246, United States
Pfizer Investigational Site
El Paso, Texas, 79925, United States
Pfizer Investigational Site
El Paso, Texas, 79935, United States
Pfizer Investigational Site
San Antonio, Texas, 78229, United States
Pfizer Investigational Site
San Antonio, Texas, 78237, United States
Pfizer Investigational Site
Ogden, Utah, 84403, United States
Pfizer Investigational Site
Fredericksburg, Virginia, 22401, United States
Pfizer Investigational Site
Richmond, Virginia, 23221, United States
Pfizer Investigational Site
Richmond, Virginia, 23294, United States
Pfizer Investigational Site
Renton, Washington, 98055, United States
Pfizer Investigational Site
Tukwila, Washington, 98188, United States
Pfizer Investigational Site
Milwaukee, Wisconsin, 53209, United States
Pfizer Investigational Site
Camperdown, New South Wales, 2050, Australia
Pfizer Investigational Site
Wollongong, New South Wales, 2500, Australia
Pfizer Investigational Site
Herston, Queensland, 4029, Australia
Pfizer Investigational Site
Woolloongabba, Queensland, 4102, Australia
Pfizer Investigational Site
Keswick, South Australia, 5035, Australia
Pfizer Investigational Site
Box Hill, Victoria, 3128, Australia
Pfizer Investigational Site
Caulfield, Victoria, 3162, Australia
Pfizer Investigational Site
Porto Alegre, Rio Grande do Sul, 90035-170, Brazil
Pfizer Investigational Site
São Paulo, São Paulo, 01244-030, Brazil
Pfizer Investigational Site
São Paulo, São Paulo, 04231-030, Brazil
Pfizer Investigational Site
Winnipeg, Manitoba, R3E 3P4, Canada
Pfizer Investigational Site
London, Ontario, N6A 4V2, Canada
Pfizer Investigational Site
Mississauga, Ontario, L5M2V8, Canada
Pfizer Investigational Site
Oakville, Ontario, L6H 3P1, Canada
Pfizer Investigational Site
Thornhill, Ontario, L4J 1V8, Canada
Pfizer Investigational Site
Toronto, Ontario, M4N-3M5, Canada
Pfizer Investigational Site
Toronto, Ontario, M4R 2G4, Canada
Pfizer Investigational Site
Laval, Quebec, H7T 2P5, Canada
Pfizer Investigational Site
Montreal, Quebec, H1T 2M4, Canada
Pfizer Investigational Site
Saint-Jérôme, Quebec, J7Z 5T3, Canada
Pfizer Investigational Site
Vaudreuil, Quebec, J7V 8P9, Canada
Pfizer Investigational Site
St. John's, A1E 2E2, Canada
Pfizer Investigational Site
Guadalajara, Jalisco, 44340, Mexico
Pfizer Investigational Site
Guadalajara, Jalisco, 44349, Mexico
Pfizer Investigational Site
Guadalajara, Jalisco, 44660, Mexico
Pfizer Investigational Site
Guadalajara, Jalisco/Mexico, 44347, Mexico
Pfizer Investigational Site
Mexico City, Mexico City, 02990, Mexico
Pfizer Investigational Site
Mexico City, Mexico City, 03100, Mexico
Pfizer Investigational Site
Monterrey, Nuevo León, 64060, Mexico
Pfizer Investigational Site
Jalapa, Veracruz, 91020, Mexico
Pfizer Investigational Site
Mexico City, CP 14000, Mexico
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 6, 2005
First Posted
September 8, 2005
Study Start
January 1, 2003
Study Completion
June 1, 2007
Last Updated
October 31, 2008
Record last verified: 2008-10